Compounded Anti-Aging Topicals

Unlabeled white cream jar and pump bottle beside a folded towel

Topical preparations combining agents associated with epidermal turnover, antioxidant activity and skin barrier support.

FDA-approved landscape first

FDA-approved topical tretinoin products are indicated for defined dermatological uses. Where an approved product meets the clinical need, it is generally the appropriate first consideration. Status: FDA-Approved Product.

Actives and role

Tretinoin: retinoid; epidermal turnover.
Niacinamide: barrier support.
Ascorbic acid: antioxidant.
Estriol: not a component of any FDA-approved drug product. Its topical use in anti-aging preparations is supported by limited evidence. Status: Investigational or Limited Evidence.

Status: Compounded Option.

Dosage forms

Cream, gel, solution.

Safety

Retinoids are contraindicated in pregnancy. Irritation, photosensitivity and an adjustment period are expected with tretinoin. Estriol-containing topicals require specific counseling from the prescriber or pharmacist, including on use in pregnancy, breastfeeding and hormone-sensitive conditions.

Patients: Transfer a Prescription

Compounded preparations are not FDA approved. FDA does not review them for safety, effectiveness or quality before they are dispensed, and they are not equivalent to commercially available approved products. California requires a patient-specific prescription for a compounded preparation, and a pharmacy may not compound what is essentially a copy of a commercially available product unless the pharmacist documents a clinically significant difference for the individual patient or the product is in shortage. This page is general information, not medical advice.

References

Clinical review: Dor Keyvani, PharmD, Pharmacist-in-Charge, California pharmacist license RPH 75634. Clinically reviewed Oct. 20, 2026. Updated Nov. 10, 2026. See our Editorial Policy and Quality and Safety pages.